Max Healthcare Institute Ltd.
NSE: MAXHEALTH · Hospital
Snapshot
Unlock Max Healthcare Institute Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Max Healthcare Institute Limited is a prominent Indian healthcare provider operating a network of tertiary and quaternary care hospitals. The company offers a wide range of medical specialties alongside home-based health services and diagnostic solutions through its Max@Home and MaxLab platforms.
Business Model
The company generates revenue primarily through inpatient and outpatient medical services across its hospital network. Additional income streams are derived from diagnostic services via MaxLab and home healthcare solutions provided through Max@Home.
- Healthcare facilities:17
Growth Outlook
Growth is driven by the expansion of its hospital network and the scaling of diagnostic and home-care services. The company continues to focus on tertiary and quaternary care to capture high-value medical demand.
Key Risks
- Regulatory Risk. Changes in government regulations regarding healthcare pricing and medical service standards could impact profit margins.
- Operational Risk. Maintaining high standards of clinical outcomes and patient safety across a large network of facilities is critical to brand reputation.
- Competitive Landscape. The Indian private healthcare sector is highly fragmented and competitive, requiring constant investment in medical technology and talent.
- Talent Retention. The ability to attract and retain highly skilled medical professionals and specialists is essential for maintaining service quality.
Start your research today
Unlock AI insights, financials, peers and live data on Max Healthcare Institute Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹9,146 Cr
TTM · consolidated
NET PROFIT
₹1,381 Cr
TTM · consolidated
EPS
₹14.20
TTM · consolidated
RETURN ON EQUITY
12.9%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
13.7%
TTM · consolidated
P/E
62.3×
Q2 FY27 · consolidated
EV/EBITDA
34.0x
Q2 FY27 · consolidated
EBITDA MARGIN
28.7%
TTM · consolidated
NET PROFIT MARGIN
16.1%
Q2 FY27 · consolidated
DEBT TO EQUITY
0.3x
Q2 FY27 · consolidated
Peers · Hospital
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd.MAXHEALTH | ₹86,114 Cr | 62.3× | 33.98 | 15.2% | 28.7% | 12.9% | 13.7% | -22.9% |
Apollo Hospitals Enterprise Ltd.APOLLOHOSP | ₹1.22L Cr | 58.2× | 30.04 | 17.2% | 15.9% | 24.6% | 20.7% | +10.1% |
Manipal Health Enterprises LimitedMANIPALHOS | ₹85,960 Cr | — | — | — | 25.0% | — | — | — |
Aster DM Quality Care LimitedASTERDM | ₹58,738 Cr | 109.0× | 54.45 | 15.7% | 22.3% | 9.1% | 10.5% | -0.6% |
Fortis Healthcare Ltd.FORTIS | ₹57,490 Cr | 54.9× | 27.49 | 17.5% | 22.9% | 11.4% | 13.0% | -25.6% |
Narayana Hrudayalaya Ltd.NH | ₹37,484 Cr | 43.4× | 20.56 | 71.4% | 19.9% | 19.0% | 15.7% | +4.4% |
As of Q2 FY27
Financials
Max Healthcare Institute Ltd.
NSE: MAXHEALTH · Hospital
Snapshot
Unlock Max Healthcare Institute Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Max Healthcare Institute Limited is a prominent Indian healthcare provider operating a network of tertiary and quaternary care hospitals. The company offers a wide range of medical specialties alongside home-based health services and diagnostic solutions through its Max@Home and MaxLab platforms.
Business Model
The company generates revenue primarily through inpatient and outpatient medical services across its hospital network. Additional income streams are derived from diagnostic services via MaxLab and home healthcare solutions provided through Max@Home.
- Healthcare facilities:17
Growth Outlook
Growth is driven by the expansion of its hospital network and the scaling of diagnostic and home-care services. The company continues to focus on tertiary and quaternary care to capture high-value medical demand.
Key Risks
- Regulatory Risk. Changes in government regulations regarding healthcare pricing and medical service standards could impact profit margins.
- Operational Risk. Maintaining high standards of clinical outcomes and patient safety across a large network of facilities is critical to brand reputation.
- Competitive Landscape. The Indian private healthcare sector is highly fragmented and competitive, requiring constant investment in medical technology and talent.
- Talent Retention. The ability to attract and retain highly skilled medical professionals and specialists is essential for maintaining service quality.
Start your research today
Unlock AI insights, financials, peers and live data on Max Healthcare Institute Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹9,146 Cr
TTM · consolidated
NET PROFIT
₹1,381 Cr
TTM · consolidated
EPS
₹14.20
TTM · consolidated
RETURN ON EQUITY
12.9%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
13.7%
TTM · consolidated
P/E
62.3x
Q2 FY27 · consolidated
EV/EBITDA
34.0x
Q2 FY27 · consolidated
EBITDA MARGIN
28.7%
TTM · consolidated
NET PROFIT MARGIN
16.1%
Q2 FY27 · consolidated
DEBT TO EQUITY
0.3x
Q2 FY27 · consolidated
Peers · Hospital
As of Q2 FY27